The brain-immune axis continues to fascinate. In this issue of Immunity, Shaked et al. (2009) describe how miR-132 mediates an anti-inflammatory effect via the targeting of acetylcholinesterase, leading to an increase in the neurotransmitter acetylcholine.
Geula Hanin, Shani Shenhar‐Tsarfaty, Nadav Yayon, Y. H. Yau, Estelle R. Bennett, Ella H. Sklan, D. C. Rao, Tuomo Rankinen, Claude Bouchard, S. Geifman-Shochat, Sagiv Shifman, David Greenberg, Hermona Soreq
.jpg){kind=small}
Discussion(0)
No comments yet. Be the first to comment.